LONG MINI-FUTURE - PFIZER INC | Market Closed - Deutsche Boerse AG 01:53:23 2024-07-05 pm EDT | ||
| 0.46 EUR | -6.12% |
|
| 3 months | +35.29% | ||
| 6 months | -24.59% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 0.46 | -6.12% |
| 24-07-04 | 0.49 | +16.67% |
| 24-07-03 | 0.42 | -6.67% |
| 24-07-02 | 0.45 | -8.16% |
| 24-07-01 | 0.49 | +6.52% |
Delayed Quote Deutsche Boerse AG
Last update July 05, 2024 at 01:53 pm EDT
More quotesStatic data
| Product type | Warrant Knock-Out con Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
Vontobel
|
| WKN | VM6C7X |
| ISIN | DE000VM6C7X4 |
| Date issued | 2023-12-04 |
| Strike | 23.09 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.63 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.69 € |
|---|---|
| Lowest since issue | 0.22 € |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.05
USD
Average target price
31.92
USD
Spread / Average Target
+13.78%
- Stock Market
- Certificates
- Certificat
